Business News | Chandigarh University's Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies
Chandigarh University’s Biotechnology and Pharmacy programs have successfully placed 178 students in leading pharmaceutical and biotechnology companies. Additionally, 261 students secured industry internships over the past three years, reflecting a strong demand for specialized professionals in these fields. This success is attributed to the university’s integrated experiential learning model, which equips students with practical skills and industry exposure. Prominent national and global companies such as Sun Pharma, GSK, Medtronic India, and the Serum Institute of India are among the top recruiters of Chandigarh University graduates. This initiative highlights the university’s commitment to meeting the growing professional demands within the healthcare and life sciences sectors.
This news highlights a significant trend in Asia's burgeoning biotechnology and pharmaceutical sectors: the critical need for skilled talent and the proactive measures educational institutions are taking to meet this demand. Chandigarh University's success in placing a substantial number of students and securing internships underscores the robust growth of these industries across the region. As Asia continues to emerge as a global hub for pharmaceutical manufacturing, research, and healthcare innovation, the availability of a well-trained workforce becomes paramount for sustaining this expansion and attracting further investment. This also signals a positive feedback loop where industry demand drives educational innovation, which in turn fuels industry growth.
The strong industry partnerships, evidenced by recruitment from major global and national players like Sun Pharma and GSK, indicate a mature ecosystem where academia and industry collaborate effectively. This model of experiential learning is crucial for bridging the skills gap and ensuring graduates are job-ready, a common challenge in rapidly evolving tech and science fields. For the broader Asian tech ecosystem, this development signifies a strengthening of the foundational human capital necessary not only for traditional biotech but also for emerging areas like AI in drug discovery and health tech, positioning the region for continued leadership in life sciences.
Related reading
6 stories
People’s Daily rejects US claims of malicious AI distillation, warns of countermeasures
Databricks to Invest Over US$350 Million in Singapore, Double Its Workforce
Personetics Launches AI Banking Console for Relationship Managers
Anthropic Sets October Launch for Singapore Office With Local Hiring Planned
Huawei unveils new optical tech standard in challenge to Nvidia, Broadcom
